U.S. flag

An official website of the United States government

GTR Home > Tests > Sjogren-Larsson syndrome, 270200, Autosomal recessive; SLS (Sjögren-Larsson syndrome) (ALDH3A2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Indication

This is a clinical test intended for Help: Diagnosis

Clinical summary

Help

Imported from OMIM

Sjogren-Larsson syndrome (SLS) is an autosomal recessive, early childhood-onset disorder characterized by ichthyosis, impaired intellectual development, spastic paraparesis, macular dystrophy, and leukoencephalopathy. It is caused by deficiency of fatty aldehyde dehydrogenase (summary by Lossos et al., 2006).

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Astigmatism
  • Enamel hypoplasia
  • Ichthyosis
  • Macular degeneration
  • Spasticity
  • Seizure
  • Spastic paraparesis
  • Photophobia
  • Alternating exotropia
  • Abnormal hair morphology
  • Color vision defect
  • Reduced visual acuity
  • Flexion contracture
  • CNS demyelination
  • Short stature
  • Abnormal nail morphology
  • Thoracic kyphosis
  • Retinal pigment epithelial atrophy
  • Opacification of the corneal epithelium
  • Retinal thinning
  • Intellectual disability
  • Macular crystals
  • Macular dots
  • Reduced tissue fatty aldehyde dehydrogenase activity
Show all

Conditions tested

Target population

Help

Sjogren-Larsson syndrome, 270200, Autosomal recessive; SLS (diagnosis/ clinical suspition/ etiology investigation/ classification)

Citations

Not provided

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.